We are live on ! Find out more
OSCR icon

Oscar Health

220 hedge funds and large institutions have $2.34B invested in Oscar Health in 2024 Q1 according to their latest regulatory filings, with 64 funds opening new positions, 74 increasing their positions, 61 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

123% more call options, than puts

Call options by funds: $43.9M | Put options by funds: $19.7M

100% more first-time investments, than exits

New positions opened: 64 | Existing positions closed: 32

67% more capital invested

Capital invested by funds: $1.4B → $2.34B (+$940M)

21% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 61

17% more funds holding

Funds holding: 188220 (+32)

13% more funds holding in top 10

Funds holding in top 10: 89 (+1)

0.92% more ownership

Funds ownership: 79.92%80.84% (+0.92%)

Holders
220
Holders Change
+32
Holders Change %
+17.02%
% of All Funds
3.17%
Holding in Top 10
9
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+12.5%
% of All Funds
0.13%
New
64
Increased
74
Reduced
61
Closed
32
Calls
$43.9M
Puts
$19.7M
Net Calls
+$24.2M
Net Calls Change
+$16.5M
Name Holding Trade Value Shares
Change
Change in
Stake
CIP
176
Convergence Investment Partners
Florida
$198K +$182K +13,282 New
Handelsbanken Fonder
177
Handelsbanken Fonder
Sweden
$178K
CIP
178
Cornerstone Investment Partners
Georgia
$178K +$164K +11,955 New
CPWM
179
Cypress Point Wealth Management
Texas
$172K +$159K +11,582 New
FCM
180
Farallon Capital Management
California
$164K +$151K +11,000 New
Wealth Enhancement Advisory Services
181
Wealth Enhancement Advisory Services
Minnesota
$158K +$146K +10,634 New
Creative Planning
182
Creative Planning
Kansas
$153K +$141K +10,274 New
CAM
183
Cresset Asset Management
Illinois
$152K +$140K +10,221 New
SIA
184
SkyView Investment Advisors
New Jersey
$149K +$137K +10,000 New
PIWA
185
Prevail Innovative Wealth Advisors
Kansas
$149K
MLICM
186
Metropolitan Life Insurance Company (MetLife)
New York
$125K -$14.7K -1,076 -11%
PAS
187
Point72 Asia (Singapore)
Singapore
$86.5K +$79.6K +5,814 New
TRCT
188
Tower Research Capital (TRC)
New York
$81.6K -$451K -32,909 -86%
AB
189
Amalgamated Bank
New York
$78K -$122K -8,925 -63%
PNC Financial Services Group
190
PNC Financial Services Group
Pennsylvania
$75.3K +$69.2K +5,050 +31,563%
AT
191
Avalon Trust
New Mexico
$68.9K +$63.5K +4,633 New
Russell Investments Group
192
Russell Investments Group
United Kingdom
$66.4K
US Bancorp
193
US Bancorp
Minnesota
$49.3K +$42.3K +3,087 +1,342%
Osaic Holdings
194
Osaic Holdings
Arizona
$48.5K -$104K -7,617 -70%
KBC Group
195
KBC Group
Belgium
$48K +$44.2K +3,224 New
PTC
196
Private Trust Company
Ohio
$33.5K +$30.8K +2,252 New
NC
197
nVerses Capital
Florida
$25.3K +$23.3K +1,700 New
C
198
Covestor
United Kingdom
$25K -$18.5K -1,349 -45%
SSB
199
Sandy Spring Bank
Maryland
$23.2K
Nisa Investment Advisors
200
Nisa Investment Advisors
Missouri
$21.1K +$18.7K +1,365 +2,482%

OSCR Hedge Fund Activity: Q1 2024 in Review

220 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Oscar Health (OSCR) for Q1 2024, worth a combined $2.34B — up 67% from $1.4B a quarter earlier.

Buyers outnumbered sellers: 64 funds opened new OSCR positions and 32 closed out — a net gain of 32 holders — while 74 added to existing stakes and 61 trimmed.

The largest buyer was T. Rowe Price Investment Management, opening a new position worth an estimated $117M. The largest seller was VK Services, exiting entirely with an estimated $62.7M sold.

  • 220 institutional investors held Oscar Health (OSCR) as of Q1 2024, up from 188 in Q4 2023.
  • Funds reported $2.34B of Oscar Health stock for Q1 2024, up 67% quarter-over-quarter.
  • 64 funds opened new Oscar Health positions in Q1 2024 and 32 closed out, a net change of +32 holders.
  • The largest Oscar Health buyer in Q1 2024 was T. Rowe Price Investment Management, an estimated $117M added.
  • The largest Oscar Health seller in Q1 2024 was VK Services, an estimated $62.7M sold.

Based on aggregated 13F filings for Q1 2024.